Introduction
- Global expansion has changed the way regulatory teams approach submissions. What was once a market-by-market process now requires coordinated planning across multiple health authorities, evolving regulatory requirements, and cross-functional teams. As global regulatory submission volumes grow, organizations need greater visibility into regulatory activities to reduce delays, reuse submission content, and accelerate market access.
- Modern regulatory submission platforms combine regulatory intelligence, workflow automation, and centralized data management to help MedTech companies improve medical device regulatory submission consistency, reduce manual work, and manage global filings more efficiently.
- Learn how global MedTech teams manage regulatory submissions across multiple countries, and navigate challenges of the medical device submission process.
What Is a Regulatory Submission in MedTech?
- Regulatory submissions include the documentation and evidence submitted to regulatory authorities to demonstrate that a medical device meets applicable regulatory requirements for market authorization, registration, or continued compliance.
- There are several potential pathways of approval depending on the device class and whether it is based on an equivalent predicate device.
Introduction: Important Definitions for the Submission Process
| Definition | |
|---|---|
| Submission | Formal application submitted to Regulatory Agencies containing required safety and efficacy information as mandated by the FD&C Act |
| Registration | Establisment Registration is required by Medical Device Manufacturers and Distributors so the FDA can store and track these locations |
| Approval | Granted by Regulatory Agencies after determining that the submission meets the requirements for the intendet medical device including market authorization |
Regulatory Submission Process
-
- The Regulatory Submission process includes first classifying your device in order to understand the applicable regulatory controls. The FDA classifies medical devices into 3 types:
- Class I = Minimal potential for harm
- Class II = Higher risk than Class I
- Class III = Generally support or sustain human life, are implanted, or present the highest level of risk, requiring the greatest regulatory controls.
- The class category will determine the type of regulatory controls and type of submission. Different countries may have different device classifications (Class II in US vs. Class B in European Union Countries).
- The Regulatory Submission process includes first classifying your device in order to understand the applicable regulatory controls. The FDA classifies medical devices into 3 types:
Regulatory Submission Process
Key Types of Regulatory Submissions
- The FDA has several types of Regulatory Submissions in Medical Devices. The information required in this submission can be leveraged in submissions to other countries, but MedTech companies must comply with any additional or unique requirements and documentation.
FDA Regulatory Approval Pathways
| Pathway | Description |
|---|---|
| 510(k) Premarket Notification |
|
| Premarket Approval (PMA) |
|
| De Novo Classification Request |
|
Regulatory Submission and Post-Market Requirements vary globally:
- The EU Medical Device Regulation (MDR) requires conformity assessment by a Notified Body for many devices before CE marking can be affixed.
- The United Kingdom (UK) continues to evolve its regulatory framework for medical devices, including future implementation of UKCA requirements. Manufacturers should monitor MHRA guidance for current timelines and transition policies.
- Medical device registrations are specific to individual countries and are mandatory for market access. Different requirements by country should be assessed to meet local regulations, including additional testing or local agents.
Example: In China, foreign manufacturers must obtain a local Chinese agent. The National Medical Products Administration (NMPA) requires rigorous testing for device registration by an accredited lab and local type testing requirements vary depending on device classification.
Post-Market requirements can also vary across regions including, but not limited to:
- Post-Market Surveillance Plans
- Medical Device Reporting
- Post-market Surveillance Studies
- Post-Approval Studies
Why Multi-Market Regulatory Submissions Are Complex
The table below highlights some basic Regulatory Considerations for a Class II In-Vitro Diagnostic (IVD). Different regulatory authorities across various regions have unique requirements. When devising a regulatory strategy to market a device globally, it is critical to:
a) Understand local requirements for the target country; may require help from local agents that are experts in their region.
b) Consider the amount of time it will take to review and obtain any additional testing or documentation for each region.
c) Plan timelines accordingly to meet marketing milestones.
d) Strategize the timing and planning so that the first submission and approval can be leveraged in other markets.
It is a complex task to ensure a global strategy can be executed efficiently, accurately, and in the desired time-frame.
Regulatory Considerations for a Class II In-Vitro Diagnostic:
| Country | Device Classification | Regulatory Considerations |
|---|---|---|
| US | Class, II, IVD |
|
| Canada | Class, II, IVD |
|
| EU | Class B |
|
| India | Class B |
|
Build a Global Submission Strategy
Successful global submissions begin long before the first application is filed. Regulatory teams should develop a submission strategy that identifies the optimal first approval market, sequences submissions based on business priorities and regulatory dependencies, and plans for documentation reuse wherever possible. Doing a regulatory impact assessment can help with planning. Additional considerations such as local representative requirements, translation needs, and resource availability should also be incorporated early. A well-planned strategy helps reduce duplicate work, improve submission consistency, and accelerate market access across multiple regions.
How Global MedTech Teams Manage Multi-Market Filings
Due to the complexity in Managing Multi-Market Filings, combined with a fast-growing global regulatory landscape, it is critical to have an organized, centralized, and standardized way of tracking data and information from all aspects of product development. MedTech teams can manage this by implementing
Centralizing Regulatory Information
- Establishing a single source for storing documentation and data is critical to manage any filing, especially multi-market filings.
- Regulatory bodies such as the FDA and EU Notified bodies expect information across dossiers to be consistent. A centralized location for this submission ensures that there are no discrepancies across multi-market filings. 14
Standardizing Submission Processes
- Part of having the centralized system is to also harmonize information across submissions. This reduces the chance of errors and variability across submissions.
- Templates for submission may be re-used across multiple markets if they align with global standards for documentation. When leveraging data across submissions, a centralized system ensures technical files and dossiers can be appropriately managed and applied.
- Example: Core data from technical documentation used in the 510(k) pathway for the FDA can also be utilized in the EU MDR submission. Templates can be designed for aspects of submission that overlap, and the EU submission can be further expanded to require the additional unique information.14
Coordinating Cross-Functional Teams
- Mult-Marketing Filings requires coordination across multiple teams including Regulatory, Quality Assurance, Marketing, Legal, Clinical, and technical teams. There are many types of information to track that are also important for other teams to access and understand.
- A centralized system allows for clear ownership of the information that ends up as part of the submission or the strategy for the product. The workflow visibility holds appropriate teams accountable and encourages early coordination across groups, as well as prevent cross-functional misalignment.
Maintaining Portfolio Visibility
- Successful global submission management requires visibility across the entire product portfolio. Regulatory leaders need to understand which submissions are in progress, which approvals are pending, and where potential bottlenecks may affect launch timelines. Centralized dashboards help teams prioritize work, allocate resources, and provide leadership with a clear view of regulatory progress across markets.
Managing Submission Milestones and Country Dependencies
- Global submissions rarely happen independently. Many regulatory strategies rely on approvals or documentation from other markets before subsequent submissions can begin. Tracking submission milestones, country-specific dependencies, and critical deadlines helps regulatory teams coordinate activities more effectively and avoid unnecessary delays.
Reusing Documentation Across Markets
- Many submission documents share common technical information that can be adapted for multiple regulatory authorities. Maintaining standardized technical documentation and reusable submission content reduces duplicate work, improves consistency, and helps accelerate submissions while ensuring country-specific requirements are addressed.
Using Global Submission Calendars
- Managing submissions across multiple countries requires careful coordination of review timelines, renewal dates, translation activities, and local regulatory requirements. A centralized submission calendar gives teams greater visibility into upcoming milestones, supports more accurate planning, and helps reduce the risk of missed deadlines.
Common Challenges in Multi-Market Submissions
As product portfolios expand and organizations enter additional markets, regulatory complexity increases quickly. Many teams struggle to maintain consistent documentation, coordinate submissions across regions, and provide leadership with accurate, up-to-date reporting. Without centralized processes or a centralized system, these challenges can slow market access and increase compliance risk.
- Depending on the target market, having fragmented data management systems, and data silos, can significantly impact timelines and cause serious delays. Spending time re-configuring information to align with each target region can also become extremely burdensome and inefficient.
- MedTech companies, especially small companies, are likely to find new challenges when expanding their target markets globally. The challenge lies in a) understanding and tracking regulatory information from new regions to ensure compliance and b) finding a standardized approach to track this information.
- Regulatory Intelligence is critical for MedTech companies that want to market products on a global scale with efficiency, while remaining up-to-date on regulatory requirements in real-time.
- It is key to avoid:
- Inconsistent technical documentation. Maintaining multiple versions of technical files, labeling, and supporting documentation across markets increases the risk of errors and rework.
- Duplicate work. Teams often recreate similar submission documents for different countries instead of reusing approved content where appropriate.
- Disconnected product data. Regulatory information stored across spreadsheets, shared drives, and separate systems makes it difficult to maintain a single source of truth.
- Limited executive visibility. Leadership may lack real-time insight into submission status, approval timelines, resource allocation, and potential risks across the global portfolio.
Example: Submissions across Latin American Countries have High Diversity of Regulatory and Compliance Systems REF _Ref228787030 \w \h \* MERGEFORMAT 13
Establishing a core dossier for multiple regulatory submissions: a case study in the Latin America region
Challenge: Latin American regions comprise a wide-range of regulatory requirements, some of which do not align with global standards.
Solution: Collect and analyze information required across the regions of interest to understand where overlap in requests exist. Create a core dossier to streamline efforts and compile information that can be applied to the countries of interest in a more efficient manner.
Why Submission Management Is Becoming a Strategic Capability
Historically, regulatory submissions were viewed as individual projects managed market by market. Today, organizations are taking a portfolio-based approach where submissions, registrations, renewals, regulatory intelligence, and product data are connected. This shift enables regulatory teams to improve forecasting, prioritize resources, reduce duplicate work, and support faster global market expansion.
The Role of Regulatory Intelligence in Submissions
Regulatory Intelligence supports better submission planning by helping teams understand changing regulatory requirements before they impact timelines. Regulatory intelligence allows teams to navigate complex and evolving global regulatory requirements and enables MedTech teams to collect, analyze, and apply regulatory insights and proactively adapt their submissions strategy.
- Regulatory Intelligence in submissions can also help reduce submission errors and deficiencies. A common challenge is siloed and fragmented data and information, which can lead to errors or misalignment in the content of submissions.
- Intelligent platforms such as RegDesk can be seamlessly integrated into MedTech Companies workflow to avoid errors and deficiencies, ultimately saving the company time and effort. This can also improve first-pass approval rates, as these platforms proactively monitor databases and can identify regulatory trends, evolving guidance, and comparable approval pathways.
The Role of Regulatory Intelligence in Submissions
How Technology Improves Regulatory Submission Management
- Technology improves global regulatory submission management by automating and streamlining workflows. Intelligent platforms allow for a centralized regulatory database that utilizes AI-assisted workflow automation combined with human-curated regulatory intelligence. Therefore, MedTech Companies can track both internal and external information and ensure the internal data aligns with expectations from external sources. This is a real-time compliance monitoring system that integrates into MedTech Companies individual data management system.
- An essential aspect of how technology improves Regulatory Submission Management is real-time compliance monitoring. Continuous and proactive regulatory monitoring helps MedTech companies stay compliant and respond quickly to evolving regulatory changes. This is critical in environments like the EU MDR, where medical device guidance and interpretation evolve quickly.
How does Technology Improve Global Regulatory Submission Management?
Example: A MedTech company utilizes a RIM platform-based intelligent platform to manage their regulatory submission content
- When preparing for a 510(k) submission, they identify that the FDA recently approved a similar device with more stringent performance testing requirements than they originally anticipated.
- Prior to submitting anything to the FDA, Regulatory Affairs specialists communicated this information to the appropriate cross-functional teams, including technical and clinical teams.
- They were able to plan and update timelines and cost to include additional performance testing. This saved time and efforts by avoiding having to wait for FDA feedback or additional information requests, and the updated testing plan with supportive data was included in the submission package.
Best Practices for Global Submission Success
Regulatory Submission Management Best Practices:
a) Build Standardized Frameworks: templates that can be applied across submissions that contain commonalities. In a competitive market, this is one way that MedTech Teams can stay ahead and reduce the burden of duplicating efforts for multiple submissions
b) Leverage Regulatory Intelligence Early: This means understanding what is currently on the market or what has recently been approved, as well as databases that include rejections or feedback. This information can be tracked throughout development by AI-driven technology to give continuous feedback.
c) Maintain Quality Assurance: Implement systems with strong quality in mind, including consistent and traceable documentation to meet audit requirements. Quality requirements for medical devices are found in 21 CFR Part 820 and ISO 13485.These should be referenced for audit readiness.
d) Align Teams Across Functions and Regions. Encourage collaboration across teams including Regulatory, Quality, Legal, Technical, and Clinical teams. This ensures alignment on the overall strategy, and appropriate input on topics from subject matter experts.
e) Reuse Prior Approvals. Reuse regulatory documentation and prior approvals whenever possible to reduce duplicate work and accelerate submissions into additional markets.
Conclusions
- Successful global submission management requires coordinated planning, standardized documentation, regulatory intelligence, and visibility across the entire product portfolio. Organizations that connect these capabilities are better positioned to accelerate market access while maintaining compliance.
- Technology that utilizes Regulatory Intelligence for submissions is key for MedTech Companies to have a competitive advantage, and streamline global regulatory submissions.
- Global Submission Success starts with Regulatory Intelligence. MedTech Companies can implement a centralized regulatory submission system, such as RegDesk.
Image credits: DC Studio on Magnific
Q&A
What is a regulatory submission in medical devices?
A regulatory submission is a formal application to a regulatory body, such as the FDA. This submission includes the necessary data and information to support the requirements for approval of the medical device, including showing that the device meets performance and safety measures.
How do companies manage regulatory submissions across multiple markets?
MedTech companies utilize centralized regulatory submission systems and cross-functional collaboration and planning as some of the main pillars of managing multi-market regulatory filings. It is optimal to create templates that contain core data and information that can be used across multiple regions to streamline the medical device submission process.
How does regulatory intelligence improve regulatory submissions?
An important feature that regulatory intelligence can provide to improve regulatory submissions in medical devices include enabling companies to stay current on evolving and rapidly changing global requirements. It can also assist with the submission process by reducing the change for errors and improving the overall quality of the submission.
What is the biggest challenge in global regulatory submissions?
Managing changing regulatory requirements across multiple markets while keeping documentation, submissions, and cross-functional teams aligned.
